NPI: 1780746420 · LEBANON, KY 40033 · Rural Acute Care Hospital · NPI assigned 12/15/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 12/15/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 71,806 | $4.54M |
| 2019 | 58,353 | $4.21M |
| 2020 | 56,335 | $2.78M |
| 2021 | 59,139 | $2.83M |
| 2022 | 64,694 | $3.22M |
| 2023 | 62,714 | $3.12M |
| 2024 | 51,752 | $2.66M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 19,224 | 15,966 | $5.91M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 20,753 | 17,577 | $3.82M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,520 | 4,933 | $2.57M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,115 | 1,767 | $1.06M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,854 | 2,381 | $995K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,872 | 2,976 | $790K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6,691 | 5,923 | $653K |
| 71045 | Radiologic examination, chest; single view | 10,234 | 7,820 | $480K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8,872 | 1,946 | $427K |
| 96361 | Intravenous infusion, hydration; each additional hour | 15,470 | 5,657 | $425K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 10,577 | 8,411 | $391K |
| G0378 | Hospital observation service, per hour | 1,615 | 730 | $331K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 688 | 580 | $304K |
| 80053 | Comprehensive metabolic panel | 30,892 | 19,016 | $274K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 32,888 | 25,852 | $269K |
| 71046 | Radiologic examination, chest; 2 views | 4,048 | 3,418 | $216K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,661 | 2,998 | $209K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,497 | 3,120 | $187K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,676 | 4,567 | $187K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,185 | 2,653 | $185K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 8,791 | 7,388 | $170K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6,365 | 5,051 | $150K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5,682 | 4,536 | $147K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,483 | 3,679 | $144K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 250 | 213 | $141K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,236 | 1,120 | $130K |
| 74018 | 1,504 | 1,328 | $130K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 674 | 566 | $123K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,454 | 3,529 | $116K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,320 | 893 | $113K |
| 73630 | 2,300 | 1,845 | $102K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 6,559 | 2,011 | $99K |
| 93017 | 667 | 574 | $94K | |
| 73610 | 1,490 | 1,204 | $92K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,235 | 1,973 | $92K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,031 | 1,919 | $91K |
| 71250 | 445 | 363 | $77K | |
| 59025 | Fetal non-stress test | 1,013 | 625 | $70K |
| 73130 | 1,345 | 1,112 | $69K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3,235 | 2,959 | $67K |
| 36415 | Collection of venous blood by venipuncture | 18,747 | 11,199 | $66K |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,419 | 6,463 | $65K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,721 | 2,487 | $63K |
| 81001 | 13,553 | 11,470 | $63K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,985 | 1,856 | $60K |
| 84484 | 6,133 | 4,829 | $59K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,385 | 1,113 | $50K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 721 | 564 | $48K |
| 80061 | Lipid panel | 1,991 | 1,589 | $48K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,111 | 4,262 | $34K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,302 | 1,169 | $34K |
| 73560 | 727 | 553 | $33K | |
| 84703 | 4,656 | 4,041 | $32K | |
| 73030 | 734 | 558 | $30K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8,699 | 5,315 | $30K |
| 72131 | 121 | 101 | $29K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 58 | 53 | $27K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,850 | 5,579 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,089 | 1,894 | $27K |
| 86140 | 4,166 | 3,608 | $27K | |
| 83735 | 4,997 | 4,045 | $26K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,629 | 1,776 | $25K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 73 | 63 | $25K |
| 87070 | 4,384 | 3,257 | $23K | |
| 85610 | 6,213 | 5,016 | $23K | |
| 85730 | 3,683 | 3,148 | $22K | |
| 87081 | 4,590 | 4,180 | $22K | |
| 73110 | 370 | 291 | $20K | |
| 87040 | 2,031 | 1,520 | $19K | |
| 87420 | 1,947 | 1,783 | $19K | |
| 97162 | 315 | 265 | $18K | |
| 87186 | 2,149 | 1,780 | $18K | |
| 83690 | 3,810 | 3,214 | $18K | |
| 84439 | 853 | 760 | $13K | |
| 85378 | 1,927 | 1,691 | $13K | |
| 93971 | 155 | 140 | $12K | |
| 73562 | 207 | 167 | $12K | |
| 83880 | 451 | 348 | $12K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,309 | 1,072 | $10K |
| 83605 | 1,487 | 1,161 | $10K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 523 | 457 | $10K |
| 84145 | 510 | 407 | $9K | |
| 70486 | 42 | 37 | $9K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 480 | 416 | $9K |
| 82728 | 697 | 581 | $8K | |
| 82150 | 1,738 | 1,481 | $7K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,434 | 1,981 | $7K |
| 71271 | 73 | 54 | $7K | |
| J2704 | Injection, propofol, 10 mg | 1,803 | 1,490 | $7K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 119 | 109 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,553 | 1,280 | $6K |
| 97597 | 219 | 70 | $6K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 27 | 26 | $6K |
| 73090 | 143 | 120 | $6K | |
| 96376 | 391 | 324 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,890 | 2,436 | $6K |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,566 | 1,199 | $6K |
| 93225 | 32 | 24 | $5K | |
| 81003 | 1,376 | 1,200 | $5K | |
| 73590 | 75 | 65 | $5K | |
| 84702 | 415 | 289 | $5K | |
| 76536 | 50 | 40 | $4K | |
| 94760 | 380 | 319 | $4K | |
| 73080 | 58 | 40 | $4K | |
| 82947 | 1,215 | 500 | $3K | |
| 62323 | 17 | 13 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,568 | 1,267 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 126 | 91 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 144 | 48 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,365 | 1,099 | $3K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,084 | 878 | $3K |
| 82803 | 183 | 142 | $3K | |
| 36600 | 203 | 142 | $3K | |
| 93242 | 16 | 13 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 882 | 659 | $3K |
| 85651 | 492 | 419 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,533 | 1,265 | $3K |
| 12001 | 45 | 38 | $2K | |
| 72100 | 40 | 37 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 308 | 275 | $2K |
| 82607 | 168 | 139 | $2K | |
| 76000 | 34 | 24 | $2K | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 1,037 | 837 | $2K |
| 87205 | 128 | 115 | $2K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 863 | 746 | $2K |
| 86850 | 210 | 165 | $2K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 353 | 335 | $2K |
| 83615 | 357 | 276 | $1K | |
| 73502 | 61 | 38 | $1K | |
| 76642 | 13 | 13 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 789 | 675 | $1K |
| 86308 | 65 | 62 | $1K | |
| 83540 | 199 | 173 | $1K | |
| 83550 | 131 | 122 | $972.12 | |
| Q3014 | Telehealth originating site facility fee | 161 | 134 | $946.65 |
| 84436 | 77 | 67 | $878.28 | |
| 97161 | 14 | 13 | $848.02 | |
| 29125 | 14 | 13 | $777.26 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 18 | 18 | $711.04 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 99 | 13 | $708.32 |
| J3490 | Unclassified drugs | 4,574 | 2,626 | $600.17 |
| 74022 | 12 | 12 | $576.35 | |
| 87522 | Neg quan hep c or qual rna | 15 | 13 | $559.48 |
| 87210 | 140 | 122 | $414.61 | |
| A9270 | Non-covered item or service | 175 | 112 | $408.33 |
| 82550 | 79 | 66 | $382.52 | |
| 87220 | 130 | 114 | $360.76 | |
| 86709 | 41 | 37 | $358.96 | |
| 82140 | 27 | 25 | $342.29 | |
| 10060 | 28 | 25 | $240.93 | |
| J2060 | Injection, lorazepam, 2 mg | 128 | 97 | $211.10 |
| 87045 | 25 | 24 | $193.53 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 69 | 58 | $153.28 |
| 0011A | 13 | 13 | $144.29 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 25 | 24 | $142.35 |
| 0012A | 13 | 13 | $141.31 | |
| 87427 | 12 | 12 | $131.60 | |
| 82746 | 13 | 12 | $123.17 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 20 | 13 | $117.94 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 33 | 27 | $116.57 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 134 | 124 | $111.82 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 67 | 57 | $89.28 |
| 82272 | 19 | 13 | $83.59 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 114 | 109 | $70.46 |
| J8540 | Dexamethasone, oral, 0.25 mg | 14 | 13 | $59.60 |
| 82570 | 12 | 12 | $57.59 | |
| 82247 | 14 | 12 | $55.76 | |
| 86901 | 13 | 12 | $37.99 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 28 | 24 | $33.75 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 28 | 24 | $28.50 |
| 86900 | 13 | 12 | $21.77 |